Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Cash from Discontinued Operations (2016 - 2018)

Historic Cash from Discontinued Operations for Soleno Therapeutics (SLNO) over the last 3 years, with Q4 2018 value amounting to -$188000.0.

  • Soleno Therapeutics' Cash from Discontinued Operations rose 6660.75% to -$188000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was -$1.4 million, marking a year-over-year increase of 5509.73%. This contributed to the annual value of -$1.4 million for FY2018, which is 5509.73% up from last year.
  • As of Q4 2018, Soleno Therapeutics' Cash from Discontinued Operations stood at -$188000.0, which was up 6660.75% from -$405000.0 recorded in Q3 2018.
  • Soleno Therapeutics' 5-year Cash from Discontinued Operations high stood at -$188000.0 for Q4 2018, and its period low was -$2.8 million during Q3 2016.
  • In the last 3 years, Soleno Therapeutics' Cash from Discontinued Operations had a median value of -$648000.0 in 2017 and averaged -$855927.2.
  • In the last 5 years, Soleno Therapeutics' Cash from Discontinued Operations surged by 7366.15% in 2017 and then skyrocketed by 4160.67% in 2018.
  • Over the past 3 years, Soleno Therapeutics' Cash from Discontinued Operations (Quarter) stood at -$1.4 million in 2016, then soared by 59.33% to -$563000.0 in 2017, then soared by 66.61% to -$188000.0 in 2018.
  • Its Cash from Discontinued Operations was -$188000.0 in Q4 2018, compared to -$405000.0 in Q3 2018 and -$281000.0 in Q2 2018.